Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6486381

Title:Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins
Inventors:Chambon, Pierre; Blaesheim, France
Summary:This invention describes a novel transgenic mouse which is deficient in the normal expression of one or more members of the RAR or RXR class of receptors. Further disclosed are cell lines, preferably pluripotent or totipotent cell lines, which are heterozygous or homozygous for such a deficiency. The authors describe ways in which such a transgenic mouse is useful in the identification of isoforms of retinoic acid or the retinoid X receptor-?a (RXR?a), bound by an agent. Also disclosed are properties in which the transgenic mouse contains heterozygous disruption in exon 4 of the gene encoding retinoid X receptor-?a (RXR?a), while exhibiting postnatal growth deficiency. Also provided are uses of such mammalian cell lines in situations where the absence of at least one RAR or RXR receptors, or the normal expression thereof, is desirable.
Abstract:The present invention provides mice which are deficient in the normal expression of one or more members of the RAR or RXR class of receptors, to mice heterozygous for such deficiency, and to cell lines, preferably pluripotent or totipotent cell lines, which are heterozygous or homozygous for such deficiency. The present invention further provides the use of any of the above mice and cell lines in situations where the absence of at least one RAR or RXR receptors, or the normal expression thereof, is desirable.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6486381
Application Number:US1999000426894
Date Filed:26/10/1999
Date Published:26/11/2000
Assignee:Institut National de la Sante et de la Recherche Medicale, Paris, France Centre National de la Recherche Scientifique, Paris, France Universite Louis Pasteur, Strasbourg, France Bristol Myers Squibb Company, Princeton, NJ, USA


 
Copyright © 2007 The Institute for Cellular Medicine  8/4/2020